Development of Nasal Vaccines and the Associated Challenges
Viruses, bacteria, fungi, and several other pathogenic microorganisms usually infect the host via the surface cells of respiratory mucosa. Nasal vaccination could provide a strong mucosal and systemic immunity to combat these infections. The intranasal route of vaccination offers the advantage of ea...
Saved in:
Main Authors: | Xuanxuan Nian (Author), Jiayou Zhang (Author), Shihe Huang (Author), Kai Duan (Author), Xinguo Li (Author), Xiaoming Yang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suspended cell lines for inactivated virus vaccine production
by: Jiayou Zhang, et al.
Published: (2023) -
Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study
by: Renfeng Fan, et al.
Published: (2022) -
Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial
by: Xiaoyuan Huang, et al.
Published: (2022) -
Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study
by: Xiaoyuan Huang, et al.
Published: (2023) -
Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness
by: Ziyan Meng, et al.
Published: (2020)